A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)

Authors

Institutions

Publication Details

Journal
Trials
Published
2026-01-30
DOI
https://doi.org/10.1186/s13063-026-09466-0
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)

Bayodé Roméo Adégbitè, Oscar Leonard Kaswaga, Hamu J. Mlyuka, Tim McHugh et al.
Trials
Tuberculosis Research and Epidemiology
article

A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)

Bayodé Roméo Adégbitè, Oscar Leonard Kaswaga, Hamu J. Mlyuka, Tim McHugh, Jeremiah Kidola, Emmanuel Mpolya, Sloan Derek, Celso Khosa, Martin J. Boeree, Peter M. Mbelele, Benno Mbeya, Belinda Chriacus Nyaulingo, Alphonce Liyoyo, Stephen H Gillespie, Samwel Lwambura, Stellah G Mpagama, Wilber Sabiiti, Hadija Semvua, Leticia Wildner, Marriot Nliwasa
article en

Abstract

No abstract available for this paper.
TrialsVol. 27(1)
Ifakara Health Institute (TZ), Radboud University Nijmegen (NL), Muhimbili University of Health and Allied Sciences (TZ), University of St Andrews (GB), Kamuzu Central Hospital (MW), Radboud University Medical Center (NL), NHS Fife (GB), Centre de Recherche Médicales de Lambaréné (GA), Victoria Hospital (GB), Instituto Nacional de Saúde (MZ), Kilimanjaro Christian Medical Centre (TZ), UCL Biomedical Research Centre (GB), National Institute for Medical Research (TZ), Kamuzu University of Health Sciences (MW), University College London (GB), Nelson Mandela African Institution of Science and Technology (TZ)
Good health and well-being
Openalex Percentile: Top 71%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.